Our top pick for
Neenah, Inc is a paper & paper products business based in the US. Neenah shares (NP) are listed on the NYSE and all prices are listed in US Dollars. Neenah employs 2,324 staff and has a trailing 12-month revenue of around USD$792.6 million.
|52-week range||USD$32.1659 - USD$60.817|
|50-day moving average||USD$55.5456|
|200-day moving average||USD$47.606|
|Wall St. target price||USD$60|
|Dividend yield||USD$1.88 (3.28%)|
|Earnings per share (TTM)||USD$3.54|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Neenah stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Neenah's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Neenah's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 13x. In other words, Neenah shares trade at around 13x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Neenah's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.85. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Neenah's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Neenah's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$101.1 million.
The EBITDA is a measure of a Neenah's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$792.6 million|
|Operating margin TTM||8.13%|
|Gross profit TTM||USD$153.2 million|
|Return on assets TTM||4.93%|
|Return on equity TTM||-4.08%|
|Market capitalisation||USD$960.1 million|
TTM: trailing 12 months
There are currently 284,898 Neenah shares held short by investors – that's known as Neenah's "short interest". This figure is 27.2% down from 391,517 last month.
There are a few different ways that this level of interest in shorting Neenah shares can be evaluated.
Neenah's "short interest ratio" (SIR) is the quantity of Neenah shares currently shorted divided by the average quantity of Neenah shares traded daily (recently around 83303.50877193). Neenah's SIR currently stands at 3.42. In other words for every 100,000 Neenah shares traded daily on the market, roughly 3420 shares are currently held short.
However Neenah's short interest can also be evaluated against the total number of Neenah shares, or, against the total number of tradable Neenah shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Neenah's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Neenah shares in existence, roughly 20 shares are currently held short) or 0.0202% of the tradable shares (for every 100,000 tradable Neenah shares, roughly 20 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Neenah.
Find out more about how you can short Neenah stock.
Dividend payout ratio: 76.42% of net profits
Recently Neenah has paid out, on average, around 76.42% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.48% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Neenah shareholders could enjoy a 3.48% return on their shares, in the form of dividend payments. In Neenah's case, that would currently equate to about $1.88 per share.
Neenah's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Neenah's most recent dividend payout was on 2 March 2021. The latest dividend was paid out to all shareholders who bought their shares by 11 February 2021 (the "ex-dividend date").
Over the last 12 months, Neenah's shares have ranged in value from as little as $32.1659 up to $60.817. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Neenah's is 1.5342. This would suggest that Neenah's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Neenah, Inc. produces and sells technical products, and fine paper and packaging products worldwide. Its Technical Products segment offers filtration media for transportation, water, and other uses; saturated and unsaturated crepe, and flat paper tapes; and coated lightweight abrasive papers for automotive, construction, metal, and woodworking industries. It also provides digital image transfer media; label and tag products for digital printing; latex saturated and coated, premask, medical packaging, digital transfer, publishing, security, clean room and durable printing, and release papers; and furniture backers. The company's Fine Paper and Packaging segment provides writing, text, cover, and specialty papers; and envelopes used in commercial printing services, corporate identity packages, and advertising collaterals. It also provides packaging products for retail, cosmetics, spirits, and electronics end-use markets; bright papers for direct mails, advertising inserts, scrapbooks, and marketing collaterals; business papers for professionals and small businesses; translucent and art papers; and papers for optical scanning and other specialized applications. The company markets its products under the JET-PRO SofStretch, KIMDURA, PREVAIL, NEENAH, GESSNER, CLASSIC, CLASSIC CREST, ENVIRONMENT, ROYAL SUNDANCE, SOUTHWORTH, TOUCHE, SO...SILK, PLIKE, STARDREAM, CONVERD, ESTATE LABEL, KIVAR, SKIVERTEX, ASTROBRIGHTS, and NEENAH IMAGEMAX brand names through authorized paper distributors, converters, retailers, and specialty businesses; and direct to end users. The company was formerly known as Neenah Paper, Inc. and changed its name to Neenah, Inc. in January 2018. Neenah, Inc. was founded in 2004 and is headquartered in Alpharetta, Georgia.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.